Cargando…
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
SREBP2 is a master regulator of the mevalonate pathway (MVP), a biosynthetic process that drives the synthesis of dolichol, heme A, ubiquinone and cholesterol and also provides substrates for protein prenylation. Here, we identify SREBP2 as a novel substrate for USP28, a deubiquitinating enzyme that...
Autores principales: | Maier, Carina R., Hartmann, Oliver, Prieto-Garcia, Cristian, Al-Shami, Kamal M., Schlicker, Lisa, Vogel, Felix C. E., Haid, Silke, Klann, Kevin, Buck, Viktoria, Münch, Christian, Schmitz, Werner, Einig, Elias, Krenz, Bastian, Calzado, Marco A., Eilers, Martin, Popov, Nikita, Rosenfeldt, Mathias T., Diefenbacher, Markus E., Schulze, Almut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307777/ https://www.ncbi.nlm.nih.gov/pubmed/37202505 http://dx.doi.org/10.1038/s41418-023-01173-6 |
Ejemplares similares
-
Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells
por: Prieto‐Garcia, Cristian, et al.
Publicado: (2020) -
Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway
por: Prieto-Garcia, Cristian, et al.
Publicado: (2021) -
Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
por: Xue, Linyuan, et al.
Publicado: (2020) -
USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K
por: Prieto‐Garcia, Cristian, et al.
Publicado: (2022) -
NRF3 upregulates gene expression in SREBP2-dependent mevalonate pathway with cholesterol uptake and lipogenesis inhibition
por: Waku, Tsuyoshi, et al.
Publicado: (2021)